gamma-aminobutyric acid has been researched along with Porphyria in 8 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Symptoms of acute porphyria have been attributed to effects of delta-aminolevulinic acid (ALA)." | 7.65 | delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. ( Müller, WE; Snyder, SH, 1977) |
| "Symptoms of acute porphyria have been attributed to effects of delta-aminolevulinic acid (ALA)." | 5.26 | delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. ( Müller, WE; Snyder, SH, 1977) |
| "Symptoms of acute porphyria have been attributed to effects of delta-aminolevulinic acid (ALA)." | 3.65 | delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. ( Müller, WE; Snyder, SH, 1977) |
| " However, results obtained with dispersed cells in culture may not necessarily reflect the situation in vivo where the cell may have a far greater resistance to the effects of toxic agents." | 1.26 | delta-Aminolaevulinic acid uptake, toxicity, and effect on [14C]gamma-aminobutyric acid uptake into neurons and glia in culture. ( Lamm, MC; Percy, VA; Taljaard, JJ, 1981) |
| "Symptoms of acute porphyria have been attributed to effects of delta-aminolevulinic acid (ALA)." | 1.26 | delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria. ( Müller, WE; Snyder, SH, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meldrum, B | 1 |
| Silbergeld, EK | 2 |
| Bonkowsky, HL | 1 |
| Schady, W | 1 |
| Hruska, RE | 1 |
| Bradley, D | 1 |
| Lamon, JM | 1 |
| Frykholm, BC | 1 |
| Percy, VA | 1 |
| Lamm, MC | 1 |
| Taljaard, JJ | 1 |
| Reynolds, NC | 1 |
| Müller, WE | 1 |
| Snyder, SH | 1 |
| Brennan, MJ | 1 |
| Cantrill, RC | 1 |
2 reviews available for gamma-aminobutyric acid and Porphyria
| Article | Year |
|---|---|
GABA and acute psychoses.
Topics: Acute Disease; Animals; Brain; Cats; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Limbi | 1982 |
Neurologic manifestations of acute porphyria.
Topics: Acute Disease; Aminolevulinic Acid; Animals; Central Nervous System; Depression; Electrophysiology; | 1982 |
6 other studies available for gamma-aminobutyric acid and Porphyria
| Article | Year |
|---|---|
Indirectly acting neurotoxins.
Topics: Aminolevulinic Acid; Animals; Brain; Dopamine; Estradiol; Female; gamma-Aminobutyric Acid; Lead Pois | 1983 |
Neurotoxic aspects of porphyrinopathies: lead and succinylacetone.
Topics: 5-Aminolevulinate Synthetase; Animals; Brain; gamma-Aminobutyric Acid; Heme; Heptanoates; Heptanoic | 1982 |
delta-Aminolaevulinic acid uptake, toxicity, and effect on [14C]gamma-aminobutyric acid uptake into neurons and glia in culture.
Topics: Aminolevulinic Acid; Animals; Brain; Cells, Cultured; Chick Embryo; Dinitrophenols; gamma-Aminobutyr | 1981 |
Epilepsy in porphyria.
Topics: 5-Aminolevulinate Synthetase; Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; | 1996 |
delta-Aminolevulinic acid: influences on synaptic GABA receptor binding may explain CNS symptoms of porphyria.
Topics: Aminolevulinic Acid; Animals; Anura; Binding, Competitive; Brain; Dose-Response Relationship, Drug; | 1977 |
Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors.
Topics: Aminolevulinic Acid; Animals; Bicuculline; gamma-Aminobutyric Acid; Levulinic Acids; Male; Picrotoxi | 1979 |